Evidence map›Paper›PMID 29384072›Full record

ArticleBioTechniques2018

Vital ex vivo tissue labeling and pathology-guided micropunching to characterize cellular heterogeneity in the tissue microenvironment.

Brian P Johnson, Ross A Vitek, Peter G Geiger, Wei Huang, David F Jarrard, Joshua M Lang, David J Beebe

Abstract read
In one paragraph

Article in BioTechniques, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Harnessing the Utility ofFrontiers in oncology · 2022
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brian P JohnsonDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI.
Ross A VitekDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI.
Peter G GeigerDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI.
Wei HuangCarbone Cancer Center, University of Wisconsin, Madison, WI.
David F JarrardCarbone Cancer Center, University of Wisconsin, Madison, WI.
Joshua M LangDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI.
David J BeebeDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Molecular and Cellular Mechanisms of Tumor DevelopmentT32CA157322 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ALEXANDER, CAROLINE M · 2011 to 2017
$1.6M
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell AnalysisR01CA181648 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BERRY, SCOTT M, LANG, JOSHUA MICHAEL · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA181648NCI NIH HHS T32 CA157322
6 · The paper itself

Abstract

Cellular heterogeneity within the tissue microenvironment may underlie chemotherapeutic resistance and response, enabling tumor evolution; however, this heterogeneity it is difficult to characterize. Here, we present a new approach-pathology-guided micropunching (PGM)-that enables identification and characterization of heterogeneous foci identified in viable human and animal model tissue slices. This technique consists of live-cell tissue labeling using fluorescent antibodies/small molecules to identify heterogeneous foci (e.g., immune infiltrates or cells with high levels of reactive oxygen species) in viable tissues, coupled with a micropunch step to isolate cells from these heterogeneous foci for downstream molecular or vital functional analysis. Micropunches obtained from epithelial or stromal fibroblast foci in human prostate tissue show 6- to 12-fold enrichment in transcripts specific for EpCam/cytokeratin 8 and vimentin/a-smooth muscle actin/integrin 1-α, respectively. Transcriptional enrichment efficiency agrees with epithelial and stromal laser capture microdissection samples isolated from human prostate. Micropunched foci show a loss of cellular viability in the periphery, but centrally localized cells retained viability before and after dissociation and grew out in culture.

Indexed as

AnimalsCell SurvivalFibroblastsFluorescent Antibody TechniqueGene Expression ProfilingHumansLaser Capture MicrodissectionMaleProstateProstatic NeoplasmsReactive Oxygen SpeciesRNATranscriptomeTumor MicroenvironmentReactive Oxygen SpeciesRNAmetabolic imagingPalkovits micropunchpathology-guided micropunchingprostatetissue microenvironmenttumor heterogeneityvital staining

Identifiers

PMID29384072
PMCPMC5814138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.